Clifford Swan Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.1M | Sell |
37,189
-1,013
| -3% | -$361K | 0.45% | 67 |
|
|
2025
Q4 | $12.5M | Sell |
38,202
-191
| -0.5% | -$60.6K | 0.41% | 69 |
|
|
2025
Q3 | $10.8M | Buy |
38,393
+212
| +0.6% | +$61.5K | 0.36% | 77 |
|
|
2025
Q2 | $10.7M | Sell |
38,181
-391
| -1% | -$111K | 0.38% | 76 |
|
|
2025
Q1 | $12M | Sell |
38,572
-253
| -0.7% | -$74.7K | 0.44% | 70 |
|
|
2024
Q4 | $10.1M | Sell |
38,825
-325
| -0.8% | -$96.4K | 0.36% | 74 |
|
|
2024
Q3 | $12.6M | Sell |
39,150
-533
| -1% | -$174K | 0.45% | 70 |
|
|
2024
Q2 | $12.4M | Sell |
39,683
-39
| -0.1% | -$11.5K | 0.46% | 62 |
|
|
2024
Q1 | $11.3M | Sell |
39,722
-386
| -1% | -$113K | 0.42% | 71 |
|
|
2023
Q4 | $11.6M | Sell |
40,108
-307
| -0.8% | -$83.6K | 0.45% | 72 |
|
|
2023
Q3 | $10.9M | Sell |
40,415
-541
| -1% | -$135K | 0.46% | 67 |
|
|
2023
Q2 | $9.09M | Sell |
40,956
-193
| -0.5% | -$44.8K | 0.37% | 80 |
|
|
2023
Q1 | $9.95M | Sell |
41,149
-215
| -0.5% | -$52.8K | 0.42% | 72 |
|
|
2022
Q4 | $10.9M | Sell |
41,364
-4
| -0% | -$1.07K | 0.47% | 68 |
|
|
2022
Q3 | $9.32M | Sell |
41,368
-254
| -0.6% | -$61.6K | 0.44% | 67 |
|
|
2022
Q2 | $10.1M | Buy |
41,622
+61
| +0.1% | +$14.9K | 0.44% | 67 |
|
|
2022
Q1 | $10.1M | Sell |
41,561
-4,344
| -9% | -$998K | 0.37% | 77 |
|
|
2021
Q4 | $10.3M | Sell |
45,905
-446
| -1% | -$94.1K | 0.36% | 79 |
|
|
2021
Q3 | $9.72M | Sell |
46,351
-365
| -0.8% | -$84K | 0.36% | 78 |
|
|
2021
Q2 | $10.7M | Sell |
46,716
-1,679
| -3% | -$413K | 0.4% | 72 |
|
|
2021
Q1 | $12M | Sell |
48,395
-1,163
| -2% | -$278K | 0.5% | 67 |
|
|
2020
Q4 | $11.4M | Sell |
49,558
-2,450
| -5% | -$565K | 0.5% | 63 |
|
|
2020
Q3 | $13.2M | Sell |
52,008
-3,674
| -7% | -$910K | 0.63% | 47 |
|
|
2020
Q2 | $13.1M | Sell |
55,682
-695
| -1% | -$159K | 0.68% | 45 |
|
|
2020
Q1 | $11.4M | Buy |
56,377
+1,610
| +3% | +$352K | 0.69% | 46 |
|
|
2019
Q4 | $13.2M | Sell |
54,767
-1,155
| -2% | -$255K | 0.64% | 51 |
|
|
2019
Q3 | $10.8M | Sell |
55,922
-97
| -0.2% | -$18.6K | 0.56% | 60 |
|
|
2019
Q2 | $10.3M | Sell |
56,019
-383
| -0.7% | -$68.6K | 0.54% | 60 |
|
|
2019
Q1 | $10.7M | Sell |
56,402
-1,981
| -3% | -$378K | 0.57% | 60 |
|
|
2018
Q4 | $11.4M | Sell |
58,383
-2,653
| -4% | -$518K | 0.69% | 52 |
|
|
2018
Q3 | $12.7M | Sell |
61,036
-1,423
| -2% | -$280K | 0.66% | 51 |
|
|
2018
Q2 | $11.5M | Sell |
62,459
-27
| -0% | -$4.78K | 0.64% | 54 |
|
|
2018
Q1 | $10.7M | Buy |
62,486
+378
| +0.6% | +$69.4K | 0.6% | 59 |
|
|
2017
Q4 | $10.8M | Buy |
62,108
+1,695
| +3% | +$300K | 0.59% | 60 |
|
|
2017
Q3 | $11.3M | Buy |
60,413
+385
| +0.6% | +$68.2K | 0.68% | 54 |
|
|
2017
Q2 | $10.3M | Buy |
60,028
+23
| +0% | +$3.74K | 0.64% | 56 |
|
|
2017
Q1 | $9.85M | Sell |
60,005
-193
| -0.3% | -$32.1K | 0.63% | 54 |
|
|
2016
Q4 | $8.8M | Buy |
60,198
+2,917
| +5% | +$439K | 0.59% | 59 |
|
|
2016
Q3 | $9.55M | Buy |
57,281
+2,928
| +5% | +$495K | 0.65% | 56 |
|
|
2016
Q2 | $8.27M | Sell |
54,353
-4,699
| -8% | -$731K | 0.57% | 63 |
|
|
2016
Q1 | $8.85M | Buy |
59,052
+543
| +0.9% | +$80.7K | 0.6% | 60 |
|
|
2015
Q4 | $9.5M | Buy |
58,509
+782
| +1% | +$123K | 0.65% | 59 |
|
|
2015
Q3 | $7.99M | Buy |
57,727
+9,446
| +20% | +$1.49M | 0.57% | 60 |
|
|
2015
Q2 | $7.41M | Sell |
48,281
-874
| -2% | -$140K | 0.5% | 62 |
|
|
2015
Q1 | $7.86M | Sell |
49,155
-1,720
| -3% | -$271K | 0.52% | 61 |
|
|
2014
Q4 | $8.1M | Sell |
50,875
-1,295
| -2% | -$202K | 0.53% | 54 |
|
|
2014
Q3 | $7.33M | Sell |
52,170
-1,485
| -3% | -$194K | 0.5% | 58 |
|
|
2014
Q2 | $6.35M | Buy |
53,655
+1,250
| +2% | +$145K | 0.43% | 66 |
|
|
2014
Q1 | $6.46M | Buy |
52,405
+784
| +2% | +$95.1K | 0.45% | 63 |
|
|
2013
Q4 | $5.89M | Sell |
51,621
-2,734
| -5% | -$311K | 0.43% | 67 |
|
|
2013
Q3 | $6.08M | Sell |
54,355
-1,191
| -2% | -$129K | 0.49% | 62 |
|
|
2013
Q2 | $5.48M | Buy |
+55,546
| New | +$5.76M | 0.46% | 64 |
|
Other funds holding AMGN
VCM
VPM
Clifford Swan Investment Counsel's AMGN Position: Q1 2026 in Review
Clifford Swan Investment Counsel reduced its Amgen (AMGN) stake by 2.7% in Q1 2026, selling an estimated $361K and leaving 37,189 shares worth $13.1M. The position accounts for 0.45% of the portfolio, ranked #67.
Clifford Swan Investment Counsel first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.2M in Q3 2020. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Clifford Swan Investment Counsel held 37,189 shares of Amgen worth $13.1M as of Q1 2026.
- Clifford Swan Investment Counsel sold 1,013 Amgen shares in Q1 2026, an estimated $361K.
- Amgen made up 0.45% of Clifford Swan Investment Counsel's portfolio in Q1 2026, its #67 holding.
- Clifford Swan Investment Counsel first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Clifford Swan Investment Counsel's Amgen position peaked at $13.2M in Q3 2020.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Clifford Swan Investment Counsel's 13F filing for Q1 2026, filed 6 May 2026.